June Sherie Almenoff - Sep 30, 2022 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
Director
Signature
/s/ Jennifer Zoltoski, by Power of Attorney
Stock symbol
AVTX
Transactions as of
Sep 30, 2022
Transactions value $
$0
Form type
4
Date filed
10/3/2022, 04:28 PM
Previous filing
Jul 1, 2022
Next filing
Jan 3, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AVTX Stock Option (Right to Buy) Award $0 +605 $0.00 605 Sep 30, 2022 Common Stock 605 $3.32 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% of the stock option will immediately vest on the date that it is granted.